Delivery Order SPE2DB22D1106-SPE2DB25FEHG7
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB24D1205|SPE2DB25FCUVA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,730.08, is for the delivery of the pharmaceutical product NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML. The contract is a firm fixed-price delivery order with a period of performance through March 12, 2025. The contract was not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,240.95, is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,035.48 firm fixed price delivery order is for the supply of NEULASTA 6 MG/0.6 ML SYRINGE 0.6ML, a specialty medication, with a performance period through April 2025. The contract is not designated with a set-aside and represents open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,251.85, is for the delivery of Neulasta OnPro 6 mg/0.6 mL kits. This is a firm fixed-price delivery order with a completion date of June 5, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The delivery order, valued at $7,092.23, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,349.28 firm fixed-price delivery order is for the supply of the drug Neulasta OnPro, a biologic medication used to help prevent infections in cancer patients undergoing chemotherapy. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2022. It...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,280.59, is for the supply of Neulasta OnPro 6 mg/0.6 ml kits, a medication used to treat certain types of cancer. The contract is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.78 firm fixed-price delivery order is for the supply of NEUPOGEN 300 MCG/ML VIALML, a specialty pharmaceutical product, with a contract period ending on February 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
This federal contract award, SPE2DX22D0029|SPE2D825F12NL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,314.26 firm fixed-price delivery order contract has an ultimate completion date of January 13, 2025. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...